Brain tumor organoids may be key to time-sensitive treatments for glioblastomas: Glioblastoma organoids grown from patient tissue can be rapidly deployed to investigate personalized treatment approaches

Lab-grown brain organoids developed from a patient's own glioblastoma, the most aggressive and common form of brain cancer, may hold the answers on how to best treat it. A new study showed how glioblastoma organoids could serve as effective models to rapidly test personalized treatment strategies.



See posts by others with similar interest